Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
Apostolia Tsimberidou, Jorge Cortes, Deborah Thomas, Guillermo Garcia-Manero, Srdan Verstovsek, Stephan Faderl, Maher Albitar, Hagop Kantarjian, Elihu Estey, Francis J. GilesVolume:
27
Year:
2003
Language:
english
Pages:
5
DOI:
10.1016/s0145-2126(03)00022-5
File:
PDF, 58 KB
english, 2003